होम › लिम्फोमा › मेसाचुसेट्स › Boston
Boston, MA में लिम्फोमा क्लिनिकल ट्रायल
Boston (लगभग 30 मील के भीतर) की साइटों पर लिम्फोमा के लिए 33 अध्ययन प्रतिभागियों की तलाश में हैं। यह देखने के लिए कि कौन शामिल हो सकता है और अध्ययन टीम से कैसे संपर्क करें, एक अध्ययन खोलें।
आधिकारिक अध्ययन पाठ (अंग्रेजी)
यहाँ अध्ययन के लिए भर्ती कर रहे हैं? इसे इस पृष्ठ के शीर्ष पर फीचर करें — 30 दिनों के लिए $99 →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
भर्ती जारीचरण 1
- Beth Israel Deaconess Medical Center - Research, Boston
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
भर्ती जारीचरण 2
- Dana-Farber Cancer Institute, Boston
A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
भर्ती जारी
- Mass General Hospital, Boston
Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
भर्ती जारी
- Mass General Brigham, Boston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
भर्ती जारीचरण 1/2
- Dana Farber Cancer Institute., Boston
Epco, Zanu, Ritux for R/R FL or MZL
भर्ती जारीचरण 2
- Dana-Farber Cancer Institute, Boston
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
भर्ती जारीचरण 1/2
- Research Site, Boston
- Research Site, Boston
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
भर्ती जारीचरण 1/2
- Dana-Farber Cancer Institute, Boston
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
भर्ती जारीचरण 3
- Research Site, Boston
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
भर्ती जारीचरण 1/2
- Massachusetts General Hospital, Boston
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
भर्ती जारीचरण 1/2
- Massachusetts General Hospital, Boston
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
भर्ती जारीचरण 4
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
The CARDIOPROTECT Trial
भर्ती जारीचरण 2
- Beth Israel Deaconess Medical Center, Boston
DALY II USA/ MB-CART2019.1 for DLBCL
भर्ती जारीचरण 2
- Dana Farber Cancer Institute, Boston
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
भर्ती जारीचरण 1/2
- Call for Information (Investigational Site 0026), Boston
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
भर्ती जारीचरण 1/2
- Dren Investigational Site, Boston
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
भर्ती जारीअवलोकनात्मक अध्ययन
- Dana-Farber Cancer Institute, Boston
Remote Monitoring and Symptom Management Digital Application
भर्ती जारी
- Massachusetts General Hospital, Boston
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
भर्ती जारी
- Massachusetts General Hospital Cancer Center, Boston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
भर्ती जारीचरण 1/2
- Dana Farber Cancer Institute, Boston
Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial
भर्ती जारी
- Dana Farber Cancer Institute, Boston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
भर्ती जारीचरण 2
- Dana-Farber Cancer Institute, Boston
Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma
भर्ती जारीचरण 2
- Beth Israel Deaconess Medical Center, Boston
Odronextamab in Low Tumor Volume Advanced FL
भर्ती जारीचरण 2
- Beth Israel Deaconess Medical Center, Boston
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
भर्ती जारीचरण 2
- Beth Israel Deaconess Medical Center, Boston
A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
भर्ती जारीचरण 2
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
भर्ती जारीचरण 2
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL
भर्ती जारीचरण 1
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
CONFIRM: Magnetic Resonance Guided Radiation Therapy
भर्ती जारी
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Avo In R/R And Previously Untreated MCL
भर्ती जारीचरण 1/2
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Mosunetuzumab for CLL MRD Clearance
भर्ती जारीचरण 1/2
- Brigham & Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia
भर्ती जारीचरण 2
- Dana Farber Cancer Institute, Boston
HEME Home Transfusion Program
भर्ती जारी
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
अन्य शहरों में लिम्फोमा ट्रायल
- Houston, TX34 अध्ययन
- New York City, NY33 अध्ययन
- Washington, DC23 अध्ययन
- Baldwin Park, CA21 अध्ययन
- Chicago, IL20 अध्ययन
- Durham, NC17 अध्ययन
- St. Louis, MO15 अध्ययन
- Philadelphia, PA15 अध्ययन
- Cleveland, OH14 अध्ययन
- Edison, NJ12 अध्ययन
- Atlanta, GA12 अध्ययन
- Seattle, WA12 अध्ययन
Boston में अन्य अध्ययन
- स्तन कैंसर111 अध्ययन
- नॉन-स्मॉल सेल लंग कैंसर90 अध्ययन
- कैंसर (सभी प्रकार)86 अध्ययन
- कोलोरैक्टल कैंसर63 अध्ययन
- मेटास्टेटिक कैंसर63 अध्ययन
- फेफड़ों का कैंसर62 अध्ययन
- अंडाशय का कैंसर61 अध्ययन
- प्रोस्टेट कैंसर59 अध्ययन
- अवसाद52 अध्ययन
- एंडोमेट्रियल कैंसर50 अध्ययन
- हृदय अस्वस्थता44 अध्ययन
- तीव्र माइलोइड ल्यूकेमिया44 अध्ययन
ClinicalTrials.gov से, 5 अक्तू॰ 2026 को प्राप्त डेटा। प्रत्येक अध्ययन अपनी योग्यता निर्धारित करता है; अध्ययन टीम तय करती है कि कौन शामिल हो सकता है।